NSC |
Compound |
Enrichment |
Correlation |
NSC 673191 |
Null |
0.0273093708703115 |
0.27944958 |
NSC 685844 |
Null |
0.0273093708703115 |
-0.071669837 |
NSC 692655 |
D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate |
0.0273093708703115 |
-0.0082494032 |
NSC 707148 |
Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) |
0.0273093708703115 |
-0.15725337 |
NSC 707149 |
Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl- .beta.-D-galactopyranosyl)oxy]-14-hydroxy-,(3.beta.,5.beta.,16.beta.)- (9CI) |
0.0273093708703115 |
-0.16121586 |
NSC 716766 |
Null |
0.0273093708703115 |
-0.047923171 |
NSC 755302 |
2-methoxy-4-(7-methoxy-2-phenylbenzo[d]imidazo[2,1-b][1,3]thiazol-3-yl)phenol |
0.0273093708703115 |
0.36737715 |
NSC 756319 |
GW694590A |
0.0273093708703115 |
0.33585682 |
NSC 123491 |
L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) |
0.0287337488682928 |
0.22743894 |
NSC 48006 |
WLN: T6N CNJ DZ EF F- BT5OTJ EO1 |
0.0287337488682928 |
-0.11598855 |